TrialTrials2013

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial.

José Baselga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.